参考文献

［1］Tu, L. Xu, J. Ligthart, et al, In vivo comparison of arterial lumen dimensions assessed by co-registered three-dimensional (3D)quantitative coronary angiography, intravascular ultrasound and optical coherence tomography. Int J Cardiovasc Imaging, 2012;28(6): 1315-1327.

［2］Tu, Z. Huang, G. Koning, et al, A novel three-dimensional quantitative coronary angiography system: In-vivo comparison with intravascular ultrasound for assessing arterial segment length. Catheter Cardiovasc Interv, 2010; 76(2): 291-298.

［3］Hoffmann, G.S. Mintz, G.R. Dussaillant, et al, Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation, 1996; 94(6): 1247-1254.

［4］Fujii, H. Hao, M. Shibuya, et al, Accuracy of OCT, grayscale IVUS, and their combination for the diagnosis of coronary TCFA: an ex vivo validation study. JACC Cardiovasc Imaging, 2015; 8(4): 451-460.

［5］Mintz, S.E. Nissen, W.D. Anderson, et al, American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol, 2001; 37(5): 1478-1492.

［6］Kubo, A. Maehara, G.S. Mintz, et al, The dynamic nature of coronary artery lesion morphology assessed by serial virtual histology intravascular ultrasound tissue characterization. J Am Coll Cardiol, 2010; 55(15): 1590-1597.

［7］Baquet, C. Brenner, M. Wenzler, et al, Impact of Clinical Presentation on Early Vascular Healing After Bioresorbable Vascular Scaffold Implantation. J Interv Cardiol, 2017; 30(1): 16-23.

［8］Haude, H. Ince, A. Abizaid, et al, Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised,first-in-man trial. Lancet, 2016; 387(10013): 31-39.